Arformoterol Tartrate Inhalation · ARFORMOTEROL TARTRATE 15 ug/2mL · Solution · Respiratory (Inhalation) · Devatis, Inc.
NDC 73043-0052-93 · 30 POUCH in 1 CARTON / 1 VIAL in 1 POUCH / 2 mL in 1 VIAL · ANDA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Some pressure is visible, but not much — here’s everything the score found to count.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Devatis, Inc. | ARFORMOTEROL TARTRATE 15 ug/2mL | Jul 15, 2026 | Sep 2, 2026 |
| Slate Run Pharmaceuticals | ARFORMOTEROL TARTRATE 15 ug/2mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Arformoterol Tartrate Inhalation — NDC 73043-0052-93," retrieved September 3, 2026, https://drugdashboards.com/drug/73043005293.
Free to cite with attribution — see how the data is put together.